项目编号 PRJCA018977
项目标题 Pyrotinib in combination with docetaxel as first-line treatment for HER2-positive metastatic breast cancer (PANDORA): a single-arm, multicenter phase 2 trial
涉及领域 Medical
数据类型 Map
物种名称 Homo sapiens
描述信息 This study aimed to explore the efficacy and safety of pyrotinib combined with docetaxel regimen in the treatment of HER2-positive metastatic breast cancer.
样品范围 Multiisolate
发布日期 2023-08-11
出版信息
PubMed ID 文章标题 杂志名称 Doi 发表年份
38097605 Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial Nature Communications 10.1038/s41467-023-44140-y 2023
项目资金来源
机构 项目类型 授权项目ID 授权项目名称
No funding support
提交者 Xiaojia Wang (wxiaojia0803@163.com)
提交单位 Zhejiang Cancer Hospital
提交日期 2023-08-11

项目包含数据信息

资源名称 描述
BioSample (31)  show -